Advances in Diabetes and Obesity Management 2024

Friday, November 8, 2024, 7:00 AM - 5:10 PM, Art Building West, Iowa City , IA

This is one-day live activity in which experts will deliver lectures covering hot topics in diabetes and obesity and have discussion with participants.

LOCATION
Art Building West University of Iowa
141 N. Riverside Drive
Iowa City, Iowa

PARKING
A temporary parking permit is available for Lot 55/Hancher for non-UI registrants. Select the parking option during registration and a separate email will be sent with instructions to sign up for a temporary parking permit. Must register by November 1, to receive a parking permit.  For questions about parking send an email to:  [email protected] 

KEYNOTE SPEAKER
Grazia Aleppo, MD, FACE, FACP
Professor of Medicine
Director, NM Diabetes Training and Education Program
Division of Endocrinology, Metabolism and Molecular Medicine
Feinberg School of Medicine
Northwestern University

AMA PRA Category 1 Credits™ (7.50 hours), AAPA Category 1 CME credit (7.50 hours), CDR CPEU (7.50 hours), Non-Physician Attendance (7.50 hours)

1. Describe overfed-undernourished phenomenon, root causes of metabolic abnormalities, and impact of lifestyle factors on diabetes and obesity
2. Discuss the latest guidelines for personalized approach to type 2 diabetes
3. Review pertinent literature for diabetes and cardiometabolic directed treatments
4. Discuss the association between relational trauma and obesity and become competent in identifying health behavior patterns associated with trauma and obesity.
5. Discuss strategies for health behavior change when a patient has a trauma history.
6. Integrate diabetes treatment paradigms and diabetes technology
7. Discuss the pathophysiology underlying weight regulation and use of different classes of anti-obesity medications
8. Describe the risk factors, natural history, and complications of metabolic dysfunction-associated steatotic liver disease (MASLD)
9. Review how to select appropriate medical therapy based on co-morbidities and clinical features
10. Discuss the range of new anti-obesity medications which may become available in the future
11. Define the current surgical procedures for obesity
12. Discuss the expected weight loss outcomes for surgical procedures vs. medical management
13. Define the possible complications from each surgical procedure
14. Discuss the diagnostic criteria of MASLD and management options for MASLD
15. Review ASCVD risk assessment
16. Understand statin treatment and goals
17. Discuss special considerations such as ASCVD and hypertriglyceridemia, ASCVD and familial hypercholesterolemia and Statin intolerance
18. Understand the current recommendation for diagnosis and treatment of thyroid diseases

Physician $200
Nurse, Physician Assistant, Pharmacist $150
Other Diabetes Health Professional $100 
Fellow/Resident/Student $50

All but $25 of the fee is refundable if inability to attend is made known on or before November 1, 2024. Refunds will not be made after this date.  

PARKING
A temporary parking permit is available for Lot 55/Hancher for non-UI registrants. Select the parking option during registration and a separate email will be sent with instructions to sign up for a temporary parking permit. Must register by November 1, to receive a parking permit.

In support of improving patient care, the University of Iowa Roy J. and Lucille A. Carver College of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Physician Associate: The University of Iowa Roy J. and Lucille A. Carver College of Medicine has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 7.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Dietitian: Completion of RD/DTR profession-specific or IPCE activity awards CPEUs (1 IPCE credits = 1 CPEU). 

If the activity is dietetics related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (1 hour/60 minutes = 1 CPEU). 

RDs and DTRs are to select activity type 102 in their Activity Logs. Performance Indicator selection is at the learner's discretion.

Nurse and Other Health Care Provider:  A certificate of participation will be available after successful completion of the course. (It is the responsibility of licensees to determine if this continuing education activity meets the requirements of their professional licensure board.)  Iowa nurses may use participation in ACCME-accredited education toward their CE requirement for licensure.  

DISCLOSURE POLICY: University of Iowa Roy J. and Lucille A. Carver College of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Mitigation of Relevant Financial Relationships

University of Iowa Roy J. and Lucille A. Carver College of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Friday, November 8, 2024